Bashir, TufailAchison, MarcusAdamson, SimonAkpan, AsangaedemAspray, Terry J.Avenell, AlisonBurton, Louise ACvoro, VeraDonnan, Peter T.Duncan, Gordon WGeorge, JacobGordon, Adam LGregson, Celia LHapca, AdrianHume, Cheryl LJackson, ThomasKerr, SimonKilgour, Alixe H. M.Masud, TahirMcKenzie, AndrewMcKenzie, EmmaPatel, HarnishPilvinyte, KristinaRoberts, Helen C.Rossios, ChristosSayer, Avan AihieSmith, Karen TSoiza, RoySteves, Claire J.Struthers, Allan DTiwari, DivyaWhitney, JulieWitham, Miles DKemp, Paul R2024-02-062024-02-062023-11-14Bashir, T, Achison, M, Adamson, S, Akpan, A, Aspray, T J, Avenell, A, Burton, L A, Cvoro, V, Donnan, P T, Duncan, G W, George, J, Gordon, A L, Gregson, C L, Hapca, A, Hume, C L, Jackson, T, Kerr, S, Kilgour, A H M, Masud, T, McKenzie, A, McKenzie, E, Patel, H, Pilvinyte, K, Roberts, H C, Rossios, C, Sayer, A A, Smith, K T, Soiza, R, Steves, C J, Struthers, A D, Tiwari, D, Whitney, J, Witham, M D & Kemp, P R 2023, 'Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia – analyses from the LACE randomised controlled trial', PloS ONE, vol. 18, no. 11 November, e0294330. https://doi.org/10.1371/journal.pone.02943301932-6203ORCID: /0000-0002-1397-4272/work/148505596ORCID: /0000-0003-4813-5628/work/167120257https://hdl.handle.net/2164/22721Acknowledgements AAS, TA, and MDW acknowledge support from the NIHR Newcastle Biomedical Research Centre. AA acknowledges support from the Health Services Research Unit, which is core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorate. The authors acknowledge support from the NIHR Ageing Clinical Research Network and the NHS Scotland Support for Science programme. The authors would also thank the efforts of all the research nurses and other site research staff who recruited participants to the trial, all the participants, and all the staff of the Tayside Clinical Trials Unit for their support of the trial. Funding Information: The LACE trial (project reference 13/53/ 03) was funded by the Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership (https://www.nihr.ac.uk/explore-nihr/ funding-programmes/efficacy-and-mechanismevaluation.htm). The Principal Investigator of the award was MW with PK, AS, AA, PD as co applicants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and not necessarily those of the MRC, NIHR or the Department of Health and Social Care. Publisher Copyright: Copyright: © 2023 Bashir et al.181303200engSarcopeniaActivin receptorpolymorphismbody compositionfat massheightR MedicineNational Institute for Health Research (NIHR)13/53/03Medical Research Council (MRC)Supplementary DataRJournal article10.1371/journal.pone.0294330http://www.scopus.com/inward/record.url?scp=85176735112&partnerID=8YFLogxK1811